Hammond Janet MJ
Insider CIK 1829899 · AVIR Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 177,000 | — | $0 | 177,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 46,800 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 11,250 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2026-01-31 | 2026-02-03 | 14,136 | $4.24 | $59.9K | 127,665 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-01-31 | 2026-02-03 | 58,050 | — | $0 | 141,801 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 46,800 | — | $0 | 46,800 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award | 2025-01-31 | 2025-02-04 | 11,250 | — | $0 | 95,522 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2025-01-31 | 2025-02-04 | 14,134 | $3.06 | $43.3K | 81,388 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 46,800 | — | $0 | 84,272 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 14,029 | $3.84 | $53.9K | 35,362 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 46,800 | — | $0 | 93,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 225,200 | — | $0 | 225,200 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 46,800 | — | $0 | 49,391 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 196,600 | — | $0 | 196,600 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 140,400 | — | $0 | 140,400 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 190,000 | — | $0 | 190,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 160,050 | — | $0 | 160,050 | SEC↗ |